Viewing Study NCT03648333


Ignite Creation Date: 2025-12-25 @ 2:43 AM
Ignite Modification Date: 2025-12-26 @ 1:22 AM
Study NCT ID: NCT03648333
Status: COMPLETED
Last Update Posted: 2018-08-27
First Post: 2018-08-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=27)
Sponsor: Hanlim Pharm. Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module